Vanguard amends Schedule 13G/A, reports 0 shares in Evolv (NASDAQ: EVLV)
Rhea-AI Filing Summary
Evolv Technologies Holdings Inc: The Vanguard Group filed Amendment No. 3 to a Schedule 13G/A reporting 0 shares beneficially owned of Common Stock, representing 0% of the class as of 03/13/2026.
The filing includes a disclosure that Vanguard completed an internal realignment on 01/12/2026, after which certain subsidiaries report ownership separately in reliance on SEC Release No. 34-39538. The statement is signed by Ashley Grim, Head of Global Fund Administration, dated 03/26/2026.
Positive
- None.
Negative
- None.
Insights
Vanguard reports no beneficial stake in EVLV following internal realignment.
The filing states 0 shares beneficially owned and 0% ownership as of 03/13/2026, signalling no current ownership position recorded by the reporting entity for this class.
Because the filing cites the 01/12/2026 internal realignment under SEC Release No. 34-39538, separate subsidiaries now report holdings independently; subsequent filings from Vanguard subsidiaries may show different positions.
Amendment is a routine disclosure tied to reallocation of reporting responsibilities.
The filing aligns with the SEC release allowing disaggregated reporting after internal reorganization; it documents that Vanguard no longer claims beneficial ownership for securities held by those subsidiaries.
Signatory and date are provided (Ashley Grim, 03/26/2026); cash‑flow treatment and any subsidiary holdings are not reported in this amendment.